Rosen Law Firm Urges Kyverna Therapeutics, Inc. (NASDAQ: KYTX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Autor: The Rosen Law Firm, P.A.
Zdroj: Business Wire (English). 12/10/2024.
Abstrakt: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to the Company’s initial public offering conducted on February 7, 2024 (the “IPO”). Kyverna is a “clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.” [ABSTRACT FROM PUBLISHER]
Databáze: Regional Business News
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje